Newborn Screening Market( by Product: (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Newborn Screening market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 3.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.1% during the prediction period 2021 to 2027.Growth in this market is majorly driven by the increasing prevalence of newborn disorders, favourable reimbursement polcies. However, the availability of refurbished products are expected to restrain the growth of this market to certain extent during the forecast period.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Newborn Screening market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Newborn Screening market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Newborn Screening market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America accounted for the largest share of the newborn screening market in 2019

The newborn screening market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the world (RoW). North America is the largest market for newborn screening, followed by Europe. Growth in the North American market can be attributed to the availability of newborn screening programs, favorable reimbursement policies, and a strong market player presence.

The Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the large newborn pool, increasing screening rate, and rising awareness regarding early diagnosis.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Newborn Screening Market are:

Major 10 players covered, including: PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), and Recipe Chemicals+Instruments (Germany)

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Product

• Consumables
• Assay kits & reagents
• Other consumables ( columns and screening cards)
• instruments
• Disorder screening instruments
• Fully-automated instruments
• Other instruments (sei-automated instrumetns, shakers, incubatorea and etc.)
• Hearing screening instruements
• Accessories
• Devices
• Pulse oximeters

By Test

• Dry blood spot tests
• Hearing screening tets
• CCHD screening tets

By technology

• Immune assays & enzymatic assays
• Tandem mass spectrometry
• Molecular assays
• Hearing sceening technologies
• Pulse oximetry
• Other Technologies (Flouroscence, gel electrophoresis and etc.)

By End user

• Clinical Laboratories
• Hospitals

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa